⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27795289 | 0.84 | TSHR (0.31) | — | |
| SCHEMBL466011 | 0.81 | KDM4E (0.30) | — | |
| SCHEMBL657925 | 0.77 | — | — | |
| SCHEMBL8749785 | 0.76 | — | — | |
| SCHEMBL12221302 | 0.74 | — | — | |
| SCHEMBL31674978 | 0.74 | NPC1 (0.33) | — | |
| SCHEMBL658142 | 0.73 | — | — | |
| SCHEMBL8227607 | 0.71 | — | — | |
| SCHEMBL339609 | 0.71 | — | — | |
| SCHEMBL20756316 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9453017-B2 | Antiviral therapies with phospholipase D inhibitors | VANDERBILT UNIVERSITY (US) | 2016-09-27 | — | — | US | claimed |
| EP-2260839-A2 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | Merz Pharma GmbH & Co. KGaA (DE) | 2010-12-15 | — | — | EP | claimed |
| EP-1682109-B1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES | MERZ PHARMA GMBH & CO KGAA (DE) | 2008-10-15 | — | — | EP | claimed |
| EP-1838297-A1 | 1-AMINOCYCLOHEXANE-DERIVATIVES FOR THE TREATMENT OF MULTIPLE SCLEROSIS EMOTIONAL LABILITY AND PSEUDOBULBAR AFFECT | Merz Pharma GmbH & Co. KGaA (DE) | 2007-10-03 | — | — | EP | claimed |
| US-20070082956-A1 | The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity. | MERZ PHARMA GMBH & CO. KGAA (DE) | 2007-04-12 | — | — | US | claimed |
| US-20060205822-A1 | 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect | FOREST LABORATORIES, INC. (US) | 2006-09-14 | — | — | US | claimed |
| EP-1682109-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES | Merz Pharma GmbH & Co. KGaA (DE) | 2006-07-26 | — | — | EP | claimed |
| WO-2006069294-A1 | 1-AMINOCYCLOHEXANE-DERIVATIVES FOR THE TREATMENT OF MULTIPLE SCLEROSIS EMOTIONAL LABILITY AND PSEUDOBULBAR AFFECT | MERZ PHARMA GMBH & CO. KGAA (DE) | 2006-06-29 | — | — | WO | claimed |
| EP-1660058-A2 | THE USE OF 1-AMINO-ALKYLCYCLOHEXANE COMPOUNDS IN THE TREATMENT OF PAIN HYPERSENSITIVITY | Merz Pharma GmbH & Co. KGaA (DE) | 2006-05-31 | — | — | EP | claimed |
| WO-2005079779-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC Aß PEPTIDES IN AMYLOIDOPATHIES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-01 | — | — | WO | claimed |
| EP-1556019-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | Merz Pharma GmbH & Co. KGaA (DE) | 2005-07-27 | — | — | EP | claimed |
| US-20050113458-A1 | delivering to said cell an 1-aminocyclohexane derivative; for decreasing the level of at least one amyloid peptide produced by a mammalian cell that expresses amyloid precursor protein | FOREST LABORATORIES, INC. (US) | 2005-05-26 | — | — | US | claimed |
| WO-2005009421-A2 | THE USE OF 1-AMINO-ALKYLCYCLOHEXANE COMPOUNDS IN THE TREATMENT OF PAIN HYPERSENSITIVITY | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-02-03 | — | — | WO | claimed |
| EP-1318800-B1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ PHARMA GMBH & CO KGAA (DE) | 2005-01-26 | — | — | EP | claimed |
| WO-2004037234-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | WO | claimed |
| US-20040087658-A1 | Synergistic mixture; Alzheimer's disease therapy | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | US | claimed |
| US-6602862-B1 | 1-Amino-alkylcyclohexanes as trypanocidal agents | MERZ PHARMA GMBH & CO., KGAA (DE) | 2003-08-05 | — | — | US | claimed |
| EP-1318800-A1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ + CO. GmbH & Co. (DE) | 2003-06-18 | — | — | EP | claimed |
| WO-2002024186-A1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2002-03-28 | — | — | WO | claimed |
| US-20210169864-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO KGAA (DE) | 2021-06-10 | — | — | US | disclosed |
| US-20170319611-A1 | METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS | UNIV VANDERBILT (US) | 2017-11-09 | — | — | US | disclosed |
| US-20170027885-A1 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2017-02-02 | — | — | US | disclosed |
| US-9498450-B2 | 1-aminocyclohexane derivatives for the treatment of cochlear tinnitus | MERZ PHARMA GMBH & CO. KGAA (DE) | 2016-11-22 | — | — | US | disclosed |
| US-9468610-B2 | 1-aminocyclohexane derivatives for the treatment of hearing loss | MERZ PHARMA GMBH & CO. KGAA (DE) | 2016-10-18 | — | — | US | disclosed |
| US-9453017-B2 | Antiviral therapies with phospholipase D inhibitors | VANDERBILT UNIVERSITY (US) | 2016-09-27 | — | — | US | disclosed |
| EP-2386299-B1 | 1-Amino-Alkylcyclohexane derivatives for use in the treatment of tinnitus associated with hearing loss | MERZ PHARMA GMBH & CO KGAA (DE) | 2016-07-13 | — | — | EP | disclosed |
| US-20160136144-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2016-05-19 | — | — | US | disclosed |
| EP-2548552-B1 | Titration package for 1-amino-alkylcyclohexanes | MERZ PHARMA GMBH & CO KGAA (DE) | 2015-11-18 | — | — | EP | disclosed |
| EP-2931277-A1 | METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS | Vanderbilt University (US) | 2015-10-21 | — | — | EP | disclosed |
| US-20150025041-A1 | ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS | VANDERBILT UNIVERSITY (US) | 2015-01-22 | — | — | US | disclosed |
| US-20140378524-A1 | METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS | VANDERBILT UNIVERSITY | 2014-12-25 | — | — | US | disclosed |
| US-20140371260-A1 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (GE) | 2014-12-18 | — | — | US | disclosed |
| US-20140348932-A1 | IMMEDIATE RELEASE FORMULATIONS OF 1-AMINOCYCLOHEXANE COMPOUNDS, MEMANTINE AND NERAMEXANE | FOREST LAB HOLDINGS LTD (BM) | 2014-11-27 | — | — | US | disclosed |
| US-20140350114-A1 | COMPOSITIONS COMPRISING CYCLOHEXYLAMINES AND AMINOADAMANTANES | MERZ PHARMA GMBH & CO KGAA (DE) | 2014-11-27 | — | — | US | disclosed |
| US-8877814-B2 | Titration package for neramexane and its use in the treatment of an inner ear disorder | MERZ PHARMA GMBH & CO. KGAA (DE) | 2014-11-04 | — | — | US | disclosed |
| US-8834924-B2 | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2014-09-16 | — | — | US | disclosed |
| EP-2203163-B1 | Titration package for neramexane and its use in the treatment of an inner ear disorder | MERZ PHARMA GMBH & CO KGAA (DE) | 2014-08-27 | — | — | EP | disclosed |
| US-20140228440-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2014-08-14 | — | — | US | disclosed |
| EP-2760447-A1 | ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS | Vanderbilt University (US) | 2014-08-06 | — | — | EP | disclosed |
| EP-2373304-B1 | Neramexane for the treatment of mast cell mediated diseases | MERZ PHARMA GMBH & CO KGAA (DE) | 2014-07-30 | — | — | EP | disclosed |
| WO-2014093557-A1 | METHODS AND COMPOSITIONS COMPRISING AKT INHIBITORS AND/OR PHOSPHOLIPASE D INHIBITORS | VANDERBILT UNIVERSITY (US) | 2014-06-19 | — | — | WO | disclosed |
| US-8680149-B2 | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases | MERZ PHARMA GMBH & CO. KGAA (DE) | 2014-03-25 | — | — | US | disclosed |
| US-20130165522-A1 | GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20130158124-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF MAST CELL MEDIATED DISEASES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2013-06-20 | — | — | US | disclosed |
| US-20130150449-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2013-06-13 | — | — | US | disclosed |
| EP-2601937-A1 | Drinkable immediate release tablet made with direct compression of memantine or neramexane | Merz Pharma GmbH & Co. KGaA (DE) | 2013-06-12 | — | — | EP | disclosed |
| EP-2582356-A1 | GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES | Merz Pharma GmbH & Co. KGaA (DE) | 2013-04-24 | — | — | EP | disclosed |
| WO-2013049773-A1 | ANTIVIRAL THERAPIES WITH PHOSPHOLIPASE D INHIBITORS | VANDERBILT UNIVERSITY (US) | 2013-04-04 | — | — | WO | disclosed |
| US-8399519-B2 | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases | MERZ PHARMA GMBH & CO. KGAA (DE) | 2013-03-19 | — | — | US | disclosed |
| US-8394857-B2 | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | MERZ PHARMA GMBH & CO. KGAA (DE) | 2013-03-12 | — | — | US | disclosed |
| EP-2548552-A2 | Titration package for 1-amino-alkylcylohexanes | Merz Pharma GmbH & Co. KGaA (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-20120238631-A1 | COMPOSITIONS COMPRISING CYCLOHEXYLAMINES AND AMINOADAMANTANES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120046302-A1 | METHODS OF TREATING CNS DISORDERS | PAPADAKIS KELLY (US) | 2012-02-23 | — | — | US | disclosed |
| WO-2011157449-A1 | GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-12-22 | — | — | WO | disclosed |
| EP-2397122-A2 | Formulations of neramexane dosage forms | Merz Pharma GmbH & Co. KGaA (DE) | 2011-12-21 | — | — | EP | disclosed |
| EP-2386299-A2 | 1-Amino-Alkylcyclohexane derivatives for the treatment of cochlear tinnitus | Merz Pharma GmbH & Co. KGaA (DE) | 2011-11-16 | — | — | EP | disclosed |
| EP-2200600-B1 | NERAMEXANE FOR USE IN THE TREATMENT OF SUB-ACUTE TINNITUS | MERZ PHARMA GMBH & CO KGAA (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-20110254236-A1 | GROUNDED CHUCK | LAM RESEARCH AG (AT) | 2011-10-20 | — | — | US | disclosed |
| US-20110251283-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF MAST CELL MEDIATED DISEASES | MERZ PHARMA GMBH & CO., KGAA | 2011-10-13 | — | — | US | disclosed |
| US-20110236439-A1 | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2011-09-29 | — | — | US | disclosed |
| US-20110207793-A1 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS. | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-08-25 | — | — | US | disclosed |
| US-20110201665-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2011-08-18 | — | — | US | disclosed |
| US-20110178179-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-07-21 | — | — | US | disclosed |
| US-20110092600-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES | MERZ PHARMA GMBH & KGAA (DE) | 2011-04-21 | — | — | US | disclosed |
| US-20110086916-A1 | INTERVAL THERAPY FOR THE TREATMENT OF TINNITUS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-04-14 | — | — | US | disclosed |
| US-20110077304-A1 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS. | MERZ PHARMA GMBH & CO., KGAA (DE) | 2011-03-31 | — | — | US | disclosed |
| EP-2289489-A2 | Compositions comprising cyclohexylamines and aminoadamantanes | Merz Pharma GmbH & Co. KGaA (DE) | 2011-03-02 | — | — | EP | disclosed |
| US-20110028510-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2011-02-03 | — | — | US | disclosed |
| WO-2011001258-A1 | COMPOSITIONS, METHODS, AND KITS FOR TREATING VIRAL AND BACTERIAL INFECTIONS BY TOCOTRIENOLS, TOCOMONOENOLS, TOCODIENOLS, TOCOPHEROLS, AND THEIR DERIVATES | EVITA LIFE SCIENCE PTE. LTD (SG) | 2011-01-06 | — | — | WO | disclosed |
| EP-2260839-A2 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | Merz Pharma GmbH & Co. KGaA (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-2260844-A1 | Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders | Merz Pharma GmbH & Co. KGaA (DE) | 2010-12-15 | — | — | EP | disclosed |
| US-20100298441-A1 | TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298440-A1 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF HEARING LOSS | MERZ PHARMA GMBH & CO., KGAA (DE) | 2010-11-25 | — | — | US | disclosed |
| WO-2010126527-A1 | METHODS OF TREATING CNS DISORDERS | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-11-04 | — | — | WO | disclosed |
| US-20100234358-A1 | NERAMEXANE FOR THE TREATMENT OF NYSTAGMUS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-09-16 | — | — | US | disclosed |
| US-20100227852-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-09-09 | — | — | US | disclosed |
| US-20100197792-A1 | 1-Amino-Alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-08-05 | — | — | US | disclosed |
| US-20100076073-A1 | Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-03-25 | — | — | US | disclosed |
| US-20100035995-A1 | Compositions comprising Cyclohexylamines and Aminoadamantanes | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-02-11 | — | — | US | disclosed |
| US-20100028427-A1 | IMMEDIATE RELEASE FORMULATIONS OF 1-AMINOCYCLOHEXANE COMPOUNDS, MEMANTINE AND NERAMEXANE | FOREST LABORATORIES, INC. (US) | 2010-02-04 | — | — | US | disclosed |
| US-20090275597-A1 | METHODS OF TREATING CNS DISORDERS | FOREST LABORATORIES HOLDINGS LIMITED (BE) | 2009-11-05 | — | — | US | disclosed |
| EP-2111858-A1 | Novel treatment for alzheimer's disease | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2009-10-28 | — | — | EP | disclosed |
| US-20090124659-A1 | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-05-14 | — | — | US | disclosed |
| US-20090081259-A1 | 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-03-26 | — | — | US | disclosed |
| EP-1682109-B1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES | MERZ PHARMA GMBH & CO KGAA (DE) | 2008-10-15 | — | — | EP | disclosed |
| US-20070270500-A1 | Compositions Comprising Cyclohexylamines and Aminoadamantanes | DEDHIYA MAHENDRA G | 2007-11-22 | — | — | US | disclosed |
| EP-1838297-A1 | 1-AMINOCYCLOHEXANE-DERIVATIVES FOR THE TREATMENT OF MULTIPLE SCLEROSIS EMOTIONAL LABILITY AND PSEUDOBULBAR AFFECT | Merz Pharma GmbH & Co. KGaA (DE) | 2007-10-03 | — | — | EP | disclosed |
| US-20070082956-A1 | The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity. | MERZ PHARMA GMBH & CO. KGAA (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1631274-A4 | COMBINATION OF AN NMDA RECEPTOR ANTAGONIST AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR FOR THE TREATMENT OF DEPRESSION AND OTHER MOOD DISORDERS | FOREST LABORATORIES (US) | 2007-03-28 | — | — | EP | disclosed |
| EP-1765287-A2 | IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS | Merz Pharma GmbH & Co. KGaA (DE) | 2007-03-28 | — | — | EP | disclosed |
| US-20060270742-A1 | Compositions and methods for the treatment of neurodegenerative diseases | COMBINATORX, INC. | 2006-11-30 | — | — | US | disclosed |
| WO-2006119295-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | COMBINATORX, INCORPORATED (US) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006096194-A2 | DRINKABLE IMMEDIATE RELEASE TABLET MADE WITH DIRECT COMPRESSION OF MEMANTINE OR NERAMEXANE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2006-09-14 | — | — | WO | disclosed |
| US-20060205822-A1 | 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect | FOREST LABORATORIES, INC. (US) | 2006-09-14 | — | — | US | disclosed |
| US-20060198884-A1 | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane | FOREST LABORATORIES, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| EP-1684715-A2 | COMPOSITIONS COMPRISING CYCLOHEXYLAMINES AND AMINOADAMANTANES | Merz Pharma GmbH & Co. KGaA (DE) | 2006-08-02 | — | — | EP | disclosed |
| EP-1682109-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES | Merz Pharma GmbH & Co. KGaA (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2006069294-A1 | 1-AMINOCYCLOHEXANE-DERIVATIVES FOR THE TREATMENT OF MULTIPLE SCLEROSIS EMOTIONAL LABILITY AND PSEUDOBULBAR AFFECT | MERZ PHARMA GMBH & CO. KGAA (DE) | 2006-06-29 | — | — | WO | disclosed |
| EP-1631274-A2 | COMBINATION OF AN NMDA RECEPTOR ANTAGONIST AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR FOR THE TREATMENT OF DEPRESSION AND OTHER MOOD DISORDERS | Forest Laboratories, Inc. (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20060002999-A1 | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane | FOREST LABORATORIES, INC. (US) | 2006-01-05 | — | — | US | disclosed |
| US-20050203191-A1 | 1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | FOREST LABORATORIES, INC. (US) | 2005-09-15 | — | — | US | disclosed |
| WO-2005079779-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC Aß PEPTIDES IN AMYLOIDOPATHIES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-01 | — | — | WO | disclosed |
| EP-1556019-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | Merz Pharma GmbH & Co. KGaA (DE) | 2005-07-27 | — | — | EP | disclosed |
| US-20050113458-A1 | delivering to said cell an 1-aminocyclohexane derivative; for decreasing the level of at least one amyloid peptide produced by a mammalian cell that expresses amyloid precursor protein | FOREST LABORATORIES, INC. (US) | 2005-05-26 | — | — | US | disclosed |
| WO-2005044228-A2 | COMPOSITIONS COMPRISING CYCLOHEXYLAMINES AND AMINOADAMANTANES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-05-19 | — | — | WO | disclosed |
| EP-1318800-B1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ PHARMA GMBH & CO KGAA (DE) | 2005-01-26 | — | — | EP | disclosed |
| US-20050014743-A1 | Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders | FOREST LABORATORIES, INC. (US) | 2005-01-20 | — | — | US | disclosed |
| WO-2005000216-A2 | COMBINATION OF AN NMDA RECEPTOR ANTAGONIST AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR FOR THE TREATMENT OF DEPRESSION AND OTHER MOOD DISORDERS | FOREST LABORATORIES, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004037234-A2 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | WO | disclosed |
| US-20040087658-A1 | Synergistic mixture; Alzheimer's disease therapy | MERZ PHARMA GMBH & CO. KGAA (DE) | 2004-05-06 | — | — | US | disclosed |
| US-6602862-B1 | 1-Amino-alkylcyclohexanes as trypanocidal agents | MERZ PHARMA GMBH & CO., KGAA (DE) | 2003-08-05 | — | — | US | disclosed |
| EP-1318800-A1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ + CO. GmbH & Co. (DE) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002024186-A1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002024186-A1 | 1-AMINO-ALKYLCYCLOHEXANES AS TRYPANOCIDAL AGENTS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2002-03-28 | — | — | WO | disclosed |